Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.82 |
| ▸ | RAB9A | P51151 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4815928 | 0.96 | MAPT (0.77) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL223429 | 0.91 | MAPT (0.79) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL20805871 | 0.91 | MAPT (0.68) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL1951546 | 0.90 | MAPT (1.00) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL30325159 | 0.90 | MAPT (0.77) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL8916699 | 0.90 | MAPT (0.77) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL7196751 | 0.90 | MAPT (0.77) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL6018398 | 0.89 | MAPT (0.77) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL2469151 | 0.89 | MAPT (0.89) | MAPTRAB9ATDP1L3MBTL1CA1 | |
| SCHEMBL20032702 | 0.89 | MAPT (0.70) | MAPTRAB9ATDP1L3MBTL1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497561-B2 | Ink composition, organic light-emitting device using same, and manufacturing method therefor | LG CHEM, LTD. (KR) | 2025-12-16 | — | — | US | claimed |
| CN-111587275-B | Ink composition, organic light emitting device using the same, and manufacturing method therefor | 株式会社LG化学 | 2023-03-17 | — | — | CN | claimed |
| US-20200373489-A1 | Ink Composition, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2020-11-26 | — | — | US | claimed |
| CN-111587275-A | Ink composition, organic light emitting device using the same, and manufacturing method therefor | 株式会社LG化学 | 2020-08-25 | — | — | CN | claimed |
| WO-2020022830-A1 | INK COMPOSITION, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | claimed |
| US-12497561-B2 | Ink composition, organic light-emitting device using same, and manufacturing method therefor | LG CHEM, LTD. (KR) | 2025-12-16 | — | — | US | disclosed |
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250115598-A1 | BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2025-04-10 | — | — | US | disclosed |
| EP-4452978-A1 | BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2024-10-30 | — | — | EP | disclosed |
| US-20240100199-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2024-03-28 | — | — | US | disclosed |
| CN-116768914-A | Fluorinated fluorescein derivative and preparation method thereof | 中国原子能科学研究院 | 2023-09-19 | — | — | CN | disclosed |
| US-11744906-B2 | Compositions, methods, and systems for the synthesis and use of imaging agents | LANTHEUS MEDICAL IMAGING, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| EP-0517511-A2 | Process for the preparation of polyester, and its composition | POLYPLASTICS CO. LTD. (JP) | 1992-12-09 | — | — | EP | disclosed |
| US-4393233-A | FROM ISOBUTYRIC ACID, BROMINE, AND BENZENE | ALLIED CORPORATION (US) | 1983-07-12 | — | — | US | disclosed |
| US-4314052-A | Polyester which is soluble or dispersible in water, a process for its preparation and its use as a levelling auxiliary, levelling auxiliaries and processes for uniform dyeing | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-02-02 | — | — | US | disclosed |
| US-4310655-A | Polymers of p-(1,1-dimethyl-2-hydroxyethyl)benzoic acid and preparation thereof | ALLIED CORPORATION (US) | 1982-01-12 | — | — | US | disclosed |
| US-4304569-A | Formulation for brightening synthetic fibers and its preparation and use | CASSELLA AG. (DE) | 1981-12-08 | — | — | US | disclosed |
| US-4087479-A | A POLYESTER AND A POLYEPOXIDE COMPOUND | NIPPON ESTER CO., LTD. (JA) | 1978-05-02 | — | — | US | disclosed |
| US-3991034-A | POWDER PAINT | NIPPON ESTER CO., LTD. (JA) | 1976-11-09 | — | — | US | disclosed |
| US-3954901-A | HEXAKIS(ALKOXYMETHYL)MELAMINE HARDENER | NIPPON ESTER CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | MAPT 752/4885RAB9A 2539/4885TDP1 777/4885 |
| US-20250115598-A1 | BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS | MLKL, CASP1, CASP9 | MAPT 344/4885RAB9A 1432/4885TDP1 376/4885 |
| US-20240100199-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | MAPT 752/4885RAB9A 2539/4885TDP1 777/4885 |
| US-11744906-B2 | Compositions, methods, and systems for the synthesis and use of imaging agents | FABP3, TNNI3, TNNT2 | MAPT 752/4885RAB9A 2539/4885TDP1 777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.